Partner Event:
China Healthcare Summit
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.


Written by Richard Daverman, PhD.

Click a link below to view the mailing archive as if it had been sent to you.

2013-05-31 01:30Sinovac Files for Approval of its EV71 Vaccine
2013-05-30 01:30Valeant Pharma Sees Bausch & Lomb Acquisition as China Entry and more...
2013-05-29 01:30Qiagen and BioBay Announce Translational Medicine JV and more...
2013-05-28 01:30Tongjitang Chinese Medicines Acquired by Winteam for $393 Million
2013-05-26 01:30Week in Review: Hisun-Pfizer and Merck-Simcere JVs Come Into Focus
2013-05-25 01:30J&J Touts its Pharma R&D Efforts for China and more...
2013-05-24 01:30Zensun Announces Positive Data from Phase II Trials of Neucardin and more...
2013-05-23 01:30CFDA Approves Clinical Trials for Novel China AIDS Treatment and more...
2013-05-22 01:30GSK Says Lowering Prices in China Caused Higher Sales
2013-05-21 01:30More Details about Hisun-Pfizer and Merck-Simcere JVs
2013-05-19 01:30Week in Review: RuiYi Signs Up Shanghai's Genor to Develop mAb in China
2013-05-18 01:30SciClone Gains China Rights to Zensun's Heart Failure Drug
2013-05-17 01:30RuiYi and Genor Enter License and Collaboration for Novel mAb and more...
2013-05-16 01:30Amgen-Zhejiang Beta China JV to Include R&D, Manufacturing
2013-05-15 01:30WuXi PharmaTech Reports Higher Q1; Analyzes Prospects for its Business and more...
2013-05-14 01:30Vectura and KingYork Form China Respiratory JV
2013-05-12 01:30The Week in Review: Sagent Buys Out China JV Partner for $25 Million
2013-05-11 01:30ScinoPharm and Coland to Develop Oncology Drugs for China
2013-05-10 01:30Hutchison Chi-Med in Partner Talks for Cancer Drug and more...
2013-05-09 01:30Zhejiang Huahai and Oncobiologics Sign Biosimilar Pact
2013-05-08 01:30Teva's CEO Thinks China is a "Natural Fit" and more...
2013-05-07 01:30Sagent Pharma Pays $25 Million to Buy out China JV Partner
2013-05-06 01:30Want Success in China? Find an experienced Chinese Partner
2013-05-05 01:30Week in Review: Fosun Buys Israeli Laser Company for $240 Million
2013-05-04 01:30Li Ka-Shing Donates $31 Million to Medical Research Institute at Oxford
2013-05-03 01:30Zhejiang Huahai Raises $126 Million for New Production Facility and more...
2013-05-02 01:30China Budgets $48.6 Million to Monitor H7N9 Bird Flu
2013-05-01 01:30Ascletis In-Licenses China Rights to HIV Drug from Janssen and more...

 

<< Archive IndexSubscribe >>


Not a ChinaBio®Today Subscriber?

Here's what you get with a paid subscription to ChinaBio® Today:
  • Website access to all current articles and commentary
  • Full access to over 2000 archived articles on the biotech industry

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC